CASCADIAN THERAPEUTICS INC's ticker is CASC and the CUSIP is 14740B606. A total of 56 filers reported holding CASCADIAN THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $32,268,000 | -9.5% | 8,721,079 | 0.0% | 0.32% | -28.3% |
Q3 2017 | $35,669,000 | +10.1% | 8,721,079 | 0.0% | 0.44% | +20.3% |
Q2 2017 | $32,399,000 | -10.3% | 8,721,079 | 0.0% | 0.37% | -12.9% |
Q1 2017 | $36,105,000 | +101.1% | 8,721,079 | +109.3% | 0.42% | +81.6% |
Q4 2016 | $17,958,000 | – | 4,166,666 | – | 0.23% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|